Duration of dual antiplatelet therapy after drug-eluting stent implantation: will we ever reach a consensus?

被引:29
作者
Valgimigli, Marco [1 ]
Ariotti, Sara [1 ]
Costa, Francesco [1 ]
机构
[1] Erasmus MC, Thoraxctr, Rotterdam, Netherlands
关键词
BARE-METAL STENTS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; THROMBOSIS; OUTCOMES; TRIAL; CLOPIDOGREL;
D O I
10.1093/eurheartj/ehv053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1219 / 1222
页数:4
相关论文
共 50 条
  • [31] Duration of dual antiplatelet therapy after implantation of the first-generation and second-generation drug-eluting stents
    Yu, Xianpeng
    Chen, Fang
    He, Jiqiang
    Gao, Yuechun
    Wu, Changyan
    Luo, Yawei
    Zhang, Xiaoling
    Zhang, Yuchen
    Ren, Xuejun
    Lv, Shuzheng
    CORONARY ARTERY DISEASE, 2013, 24 (03) : 217 - 223
  • [32] The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
    Hu, Mengjin
    Gao, Xiaojin
    Yang, Jingang
    Yang, Yuejin
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [33] Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent Implantation
    Nakamura, Masato
    Iijima, Raisuke
    Ako, Junya
    Shinke, Toshiro
    Okada, Hisayuki
    Ito, Yoshiaki
    Ando, Kenji
    Anzai, Hitoshi
    Tanaka, Hiroyuki
    Ueda, Yasunori
    Takiuchi, Shin
    Nishida, Yasunori
    Ohira, Hiroshi
    Kawaguchi, Katsuhiro
    Kadotani, Makoto
    Niinuma, Hiroyuki
    Omiya, Kazuto
    Morita, Takashi
    Zen, Kan
    Yasaka, Yoshinori
    Inoue, Kenji
    Ishiwata, Sugao
    Ochiai, Masahiko
    Hamasaki, Toshimitsu
    Yokoi, Hiroyoshi
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (12) : 1189 - 1198
  • [34] Dual antiplatelet therapy in the drug-eluting stent era
    Wallentim, Lars
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2008, 10 (0D) : D38 - D44
  • [35] Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study
    Lee, Seung-Jun
    Choi, Dong-Woo
    Kim, Choongki
    Suh, Yongsung
    Hong, Sung-Jin
    Ahn, Chul-Min
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Park, Eun-Cheol
    Jang, Yangsoo
    Nam, Chung-Mo
    Hong, Myeong-Ki
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [36] Optimal Duration of Dual-Antiplatelet Therapy Following Drug-Eluting Stent Implantation : A Meta-Analysis
    Zhang, Tuo
    Shen, Linghong
    Hu, Liuhua
    He, Ben
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (03) : 345 - 351
  • [37] Dual Antiplatelet Therapy and Clinical Outcomes after Coronary Drug-Eluting Stent Implantation in Patients on Hemodialysis
    Chen, Yung-Tai
    Chen, Hung-Ta
    Hsu, Chien-Yi
    Chao, Pei-Wen
    Kuo, Shu-Chen
    Ou, Shuo-Ming
    Shih, Chia-Jen
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (02): : 262 - 271
  • [38] Duration of dual antiplatelet therapy in patients with acute coronary syndrome undergoing drug-eluting stent implantation: A meta-analysis
    Geng, Xue
    Zhang, Ya-Nan
    Cui, Wei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (04)
  • [39] Dual antiplatelet therapy duration after percutaneous coronary intervention with drug-eluting stents: how short can we go?
    Roccasalva, Fausto
    Ferrante, Giuseppe
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (05): : 436 - 450
  • [40] Optimal Duration of Dual Antiplatelet Therapy After Coronary Stent Implantation
    Witberg, Guy
    Lev, Eli
    Kornowsisi, Ran
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (10) : 1631 - 1636